Coronavirus disease 2019 (COVID-19) is a disease caused by a new coronavirus
called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously
known as 2019-nCoV), which was first identified in Wuhan City, Hubei Province,
PRC. The total number of COVID-19 cases worldwide has reached 102 million cases
with 54 million cases recovered and 2.3 million cases dead. Handling for this
pandemic is still being carried out. In Indonesia, the antiviral drugs used are those
that meet the Emergency Use Authorization (EUA) requirements, and are included
in the COVID-19 management guidelines issued by the Ministry of Health. Antiviral
options used are Oseltamivir, Favifirapir, Remdesivir. Until now, the use of
antivirus is still being researched regarding the effectiveness and security of the
antivirus used. Oseltamivir is used as an antiviral for COVID-19 with a mild clinical
course, Favifirapir is used for mild to moderate clinical cases of COVID-19. For the
use of remdesivir in COVID-19 patients with severe and critis clinical conditions.